Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

John R. Laird

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

Original languageEnglish (US)
Pages (from-to)757-762
Number of pages6
JournalJournal of Invasive Cardiology
Volume11
Issue number12
StatePublished - 1999
Externally publishedYes

Fingerprint

Urokinase-Type Plasminogen Activator
Ischemia
Extremities
Fibrinolytic Agents
Fibrin
Blood Vessels
Thrombosis
Therapeutics
reteplase
Surgeons

Keywords

  • Peripheral vascular disease
  • Thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia. / Laird, John R.

In: Journal of Invasive Cardiology, Vol. 11, No. 12, 1999, p. 757-762.

Research output: Contribution to journalArticle

@article{d8a642df61a14c4ba5ad1b6b75ee218a,
title = "Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia",
abstract = "The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.",
keywords = "Peripheral vascular disease, Thrombolysis",
author = "Laird, {John R.}",
year = "1999",
language = "English (US)",
volume = "11",
pages = "757--762",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "12",

}

TY - JOUR

T1 - Intra-Arterial Reteplase for the Treatment of Acute Limb Ischemia

AU - Laird, John R.

PY - 1999

Y1 - 1999

N2 - The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

AB - The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.

KW - Peripheral vascular disease

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=0000271579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000271579&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 757

EP - 762

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 12

ER -